par Stephan Lust | Nov 19, 2024 | Uncategorized
We are pleased to announce that we have signed a long-term agreement with Abacus Parenteral Drugs Limited (APDL) for the production and supply of infusion bottles (Ringer lactate (Hartmann), sodium chloride, and dextrose (5% in water)) compliant to international...
par Stephan Lust | Août 26, 2024 | Conference session
Access to quality-assured cancer medicines in low-resource settings remains a critical challenge, leading to significant disparities in cancer care and outcomes. In fact, 70% of global cancer mortalities occur in low- and middle-income countries (LMICs), where access...
par Stephan Lust | Juin 27, 2024 | Viabilité écologique
We are happy to present our 2023 Sustainability Report to you, confirming our continuing commitment to the UN Global Compact 10 principles related to Human Rights, Labour, Environment and Anti-Corruption. This report outlines our key actions in alignment with the UN...
par Stephan Lust | Mai 21, 2024 | Viabilité écologique
IDA Foundation is proud to announce that we have been awarded with a Bronze Medal in its first assessment of EcoVadis, an internationally recognised sustainability ratings provider. Even though this was IDA Foundation’s first assessment, our overall score of 63/100...
par Stephan Lust | Fév 5, 2024 | Oncology
Amsterdam/Geneva, 5 February 2024. IDA Foundation and the Access to Oncology Medicines (ATOM) Coalition are happy to announce their strategic partnership. Following World Cancer Day’s theme ‘Close the Care Gap’, this collaboration marks a significant step toward...
